Who Paid My Doc
Brineura
Biological Cln 2
NDC 68135-811-02
General payments
$382,651
Research payments
$3,719,238
Through program year 2024, $382,651 in general payments and $3,719,238 in research payments were reported against Brineura (Cln 2).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
11 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2024 | Research | $194,936 | 98 |
| 2023 | General | $39,343 | 184 |
| 2023 | Research | $700,446 | 70 |
| 2022 | General | $71,292 | 164 |
| 2022 | Research | $855,649 | 84 |
| 2021 | General | $60,267 | 180 |
| 2021 | Research | $339,446 | 32 |
| 2020 | General | $67,403 | 106 |
| 2020 | Research | $410,800 | 19 |
| 2019 | General | $144,346 | 386 |
| 2019 | Research | $1,217,962 | 29 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2023.
The top 5 of 26 specialties; each share is of general payments naming this product to practitioners with a specialty in 2023. Each practitioner is counted under their primary specialty.
The top 5 of 23 states; each share is of general payments naming this product in 2023 where a state was reported.
Records
1,020 general · 332 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.